1 yıllık getiri (CAGR)
50.06%
Johnson & Johnson Exchange (NYSE, USD)
JNJ
267.28
+0.88 (+0.33%)
HealthcareDrug Manufacturers - General
Loading...
3 yıllık getiri (CAGR)
18.50%
5 yıllık getiri (CAGR)
9.17%
10 yıllık getiri (CAGR)
8.40%
Objective Corporation Hisse Senedi Analizi – Eyalet İçinde Eyalet
Daha fazla okuPiyasa değeri
643.92B
Fiyat/Satış
6.58
Ent değeri
739.59B
Fiyat/Defter
7.58
DIV kazancı
2.01%
Büyüme yılları
58
DIV büyümesi
5.25%
FCF ödemesi
95.35%
Trailing P/E
30.61
PEG
4.78
İleri P/E
21.51
EPS büyümesi
14.90%
İş anlayişi
Temel Analizin Anlamı ve Metodolojisi (2025)
Daha fazla okuSegment Revenues ($M)
Loading...
Operations comments
In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission
The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021
Geographic Revenues ($M)
Loading...